Digestive symptoms are prominent among COVID-19 patients

Summary: Digestive symptoms, such as diarrhea and anorexia, are common in COVID-19 patients. Almost 50% of coronavirus patients from the Hubei province of China presented digestive symptoms and cited them as their main symptoms.

Source: Wolters Kluwer Health

The American Journal of Gastroenterology published today a new study that reveals digestive symptoms, including diarrhea, are common in COVID-19 patients. The study comes from the Wuhan Medical Treatment Expert Group for COVID-19 in China.

Nearly half of COVID-19 patients enrolled in the study conducted in the Hubei province of China presented digestive symptoms, such as diarrhea and anorexia, and cited it as their chief complaint. The study also reveals that patients with digestive symptoms had a longer gap between the onset of symptoms and hospital admission than patients presenting only respiratory symptoms and were less likely to be cured and discharged than those without digestive symptoms.

This shows the word covid19
Nearly half of COVID-19 patients enrolled in the study conducted in the Hubei province of China presented digestive symptoms, such as diarrhea and anorexia, and cited it as their chief complaint. The image is in the public domain.

The authors recommend that “the index of suspicion may need to be raised earlier in at-risk patients presenting with digestive symptoms rather than waiting for respiratory symptoms to emerge.”

About this coronavirus research article

Source:
Wolters Kluwer Health
Media Contacts:
Brennan M. R. Spiegel – Wolters Kluwer Health
Image Source:
The image is in the public domain.

Original Research: Open access (PDF)
“Clinical characteristics of COVID-19 patients with digestive
symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study”.
Martin Trapecar, Catherine Communal, Lei Pan, MD, PhD et al.
American Journal of Gastroenterology doi:14309/ajg.0000000000000620.

Abstract

Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study

Background: Since the outbreak of Corona Virus Disease 2019 (COVID-19) in December 2019, various digestive symptoms have been frequently reported in patients infected with the virus. In this study, we aimed to further investigate the prevalence and outcomes of COVID19 patients with digestive symptoms.

Methods: In this descriptive, cross-sectional, multicenter study, we enrolled confirmed patients with COVID-19 who presented to three hospitals from January 18th to February 28th, 2020. All patients were confirmed by real-time RT-PCR and were analyzed for clinical characteristics, laboratory data, and treatment. Data were followed up until March 5th, 2020.

Results: In the present study, 204 patients with COVID-19 and full laboratory, imaging, and historical data were analyzed. The average age was 54.9 years (SD +15.4), including 107 men and 97 women. We found that 99 patients (48.5%) presented to the hospital with digestive symptoms as their chief complaint. Patients with digestive symptoms had a significantly longer time from onset to admission than patients without digestive symptoms (9.0 days vs. 7.3 days). Patients with digestive symptoms had a variety of manifestations, such as anorexia (83 [83.8%] cases), diarrhea (29 [29.3%] cases), vomiting (8 [0.8%] cases), and abdominal pain (4 [0.4%] cases). In 7 cases there were digestive symptoms but no respiratory symptoms. As the severity of the disease increased, digestive symptoms became more pronounced. Patients without digestive symptoms were more likely to be cured and discharged than patients with digestive symptoms (60% vs. 34.3%). Laboratory data revealed no significant liver injury in this case series.

Conclusion: We found that digestive symptoms are common in patients with COVID-19. Moreover, these patients have a longer time from onset to admission and their prognosis is worse than patients without digestive symptoms. Clinicians should recognize that digestive symptoms, such as diarrhea, may be a presenting feature of COVID-19, and that the index of suspicion may need to be raised earlier in at-risk patients presenting with digestive symptoms rather than waiting for respiratory symptoms to emerge. However, further large sample studies are needed to confirm these findings.

Feel Free To Share This COVID-19 News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.